B12 and Skin hyperpigmentation - a phase IV clinical study of FDA data

Summary:

Skin hyperpigmentation is reported as a side effect among people who take B12 (cobalamin), especially for people who are female, 60+ old, also take Revlimid, and have Acne.

The phase IV clinical study analyzes which people have Skin hyperpigmentation when taking B12. It is created by eHealthMe based on reports of 119,647 people who have side effects when taking B12 from the FDA, and is updated regularly.

What is B12?

B12 has active ingredients of cobalamin. It is often used in vitamin b12 deficiency. eHealthMe is studying from 121,894 B12 users. Check the latest studies of B12.

What is Skin hyperpigmentation?

Skin hyperpigmentation (disorders affect the colour of your skin) is found to be associated with 648 drugs and 811 conditions by eHealthMe. Check the latest studies of Skin hyperpigmentation.

On Jul, 04, 2026

119,647 people reported to have side effects when taking B12.
Among them, 43 people (0.04%) have Skin hyperpigmentation.

Among these 43 people:

What is the gender of people who have Skin hyperpigmentation when taking B12? *

female: 89.74 %
male: 10.26 %

What is the age of people who have Skin hyperpigmentation when taking B12? *

What are other drugs people take besides B12? *

What are other side effects people have besides Skin hyperpigmentation? *

Rashes (redness): 16 people, 37.21%
Dry Skin: 9 people, 20.93%
Itching: 8 people, 18.60%
Nausea (feeling of having an urge to vomit): 7 people, 16.28%
Stress And Anxiety: 7 people, 16.28%
Chest Pain: 7 people, 16.28%
Skin Burning Sensation: 6 people, 13.95%
Dyspnea (difficult or laboured breathing): 6 people, 13.95%
Weakness: 5 people, 11.63%
Hypoaesthesia (reduced sense of touch or sensation): 5 people, 11.63%

What are the existing conditions these people have? *

Acne (skin problems that cause pimples): 8 people, 18.60%
Multiple Myeloma (cancer of the plasma cells): 7 people, 16.28%
High Blood Pressure: 6 people, 13.95%
Pain: 3 people, 6.98%
Gout (uric acid crystals building up in the body): 3 people, 6.98%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 6.98%
Lung Adenocarcinoma Metastatic (a form of non-small cell lung cancer spreads to other part): 2 people, 4.65%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 2 people, 4.65%
Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 4.65%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 4.65%

* Approximation only. Some reports may have incomplete information.

Do you take B12 and have Skin hyperpigmentation?

- Check whether Skin hyperpigmentation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to B12:

B12 (121,894 reports)

Browse all side effects of B12:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin hyperpigmentation:

Skin hyperpigmentation (648 drugs)

Browse all the conditions that are associated with Skin hyperpigmentation:

Skin hyperpigmentation (811 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cobalamin (the active ingredients of B12) and B12 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.